Fill Finish Pharmaceutical Contract Manufacturing Market: Fill Finish Manufacturing Considerations
Roots Analysis
Market research & consulting services in the pharma / biopharma, medical devices & contract manufacturing domains
Fill finish is the final step in downstream processing of a product, wherein the purified formulation of the small molecules is mixed with the necessary excipients and stabilizers. The product is then formulated and aliquoted into the appropriate dosage forms for clinical use or commercial distribution. These operations are automated and are usually carried out under aseptic conditions. Unit operations involved in the fill finish process include compounding and mixing, filling, lyophilization, closing, sealing, sorting, inspection, labeling and packaging of the product.
As the pharmaceutical sector has evolved over the past several years, the concept of vertical integration has gradually eroded. In fact, due to a pressing need to reduce costs and improve efficiency in the global pharma supply chain, the industry has witnessed a paradigm shift from vertically integrated business model to a network of suppliers. Pharmaceutical players have started opting services from contract manufacturing organizations in order to meet their fundamental needs and specified competencies while meeting the stringent regulatory criteria’s. As a result, outsourcing has increasingly gained prominence in the industry and allows pharmaceutical companies to utilize the resources of third-party service providers on a contract basis.
Presently, contract fill finish services are among the most outsourced services in the pharmaceutical domain. Almost every pharma and biotechnology company outsource a major portion of their fill / finish requirements. Start-ups outsource their manufacturing or fill / finish operations to CMOs (contract manufacturing organizations) owing to the lack of capacity and well-established resources, whereas companies having their own in-house fill / finish capacity outsource nearly 50% of their fill / finish needs, primarily to reduce the supply chain risks, gain access to specialized technologies, and meet unexpected rise in demand.
For detailed information:
Email: sales@rootsanalysis.com
Fill Finish Pharmaceutical Contract Manufacturing Market Size
According to Roots Analysis, the global market for fill finish pharmaceutical contract manufacturing is estimated to be around USD 7.2 billion in 2024 and expected to grow at a CAGR of 4.8%, during the forecast period till 2035. In terms of type of fill finish service offered, currently majority share (44%) of the global fill finish pharmaceutical contract manufacturing market is likely to be captured by terminal sterilization. Further, low potent API capture the maximum share (86%) of the current fill finish pharmaceutical contract manufacturing market; notably, in the coming future, there will be a rise in the outsourcing of fill finish pharmaceutical services.
Growth of the fill finish pharmaceutical contract manufacturing market is driven by several factors, such as growing pipeline of small molecule drug products, growing adoption of advanced technologies and enhanced operational flexibility in this domain.
Fill Finish Pharmaceutical Contract Manufacturing Market Landscape
The current market landscape comprises of close to 390 companies (including large, mid-sized, and small firms) that offer fill finish manufacturing services, across different regions. Notably, proportion of the companies (93%) offer services for aseptic filling to various small molecules developers. In addition, for filling of cartridges, close to 50% of the capacity is installed in Europe.
Key Fill Finish Pharmaceutical Contract Manufacturing Companies
Examples of key fill finish pharmaceutical contract manufacturing companies (which have also been profiled in this report) include (in alphabetical order) Alcami, Amanta Healthcare, Aurigene Services, Batterjee Pharma, Burrard Pharmaceuticals, Curida, Eriochem, Fresenius Kabi, GlaxoSmithKline, Nextar Chempharma Solutons, Pfizer CentreOne, Plastikon Healthcare, Procaps, Recipharm, ROMMELAG CMO, Sharp, Sypharma, Teva Pharmaceuticals and WuXi AppTec.
All your Questions Related to Fill Finish Pharmaceutical Contract Manufacturing Market Answered in this Report
The Fill Finish Pharmaceutical Contract Manufacturing Market, till 2035 report features an extensive study of the current market landscape, market size and future opportunities associated with the fill finish pharmaceutical contract manufacturing market, during the given forecast period. Further, the market report highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the pharmaceutical industry. The report answers many key questions related to this market. Click on the below link to know more about this emerging area of research.
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.